Skip to main content

Table 5 Multivariate Cox Regression for recurrence using both the EORTC score and NLR 2.5 Cutoff, stratified by treatment subgroups

From: Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer

 

95.0% CI for HR

Group

Variable

P-Value

Hazard Ratio

Lower

Upper

Whole Cohort

NLR2.5

0.012

2.098

1.174

3.750

EORTC

0.058

1.112

0.996

1.241

No Treatment

NLR2.5

0.273

1.673

0.666

4.201

EORTC

0.039

1.267

1.012

1.587

MMC

NLR2.5

0.640

1.285

0.449

3.682

EORTC

0.233

1.138

0.920

1.408

BCG

NLR2.5

0.025

3.962

1.193

13.159

EORTC

0.396

1.086

0.898

1.312